Hong Kong, 5 August 2024
Opharmic Launches 2024 Rising Star Programme: Empowering High School Students in Biotech and Innovation
Opharmic Technology (HK) Limited is delighted to announce the launch of its 2024 Rising Star Programme, a specially designed summer internship initiative for high school students and recent high school graduates.
This programme offers young talents a unique opportunity to gain an early glimpse into the dynamic world of biotechnology and medtech innovation. Participants will receive hands-on experience working alongside Opharmic’s multidisciplinary team, engaging directly with real-world projects in research, development, regulatory processes, quality management, and business operations.
As dedicated scientists and innovators committed to advancing the STEM field, Opharmic designed the Rising Star Programme to nurture curiosity and passion among the next generation. The company firmly believes that high school students should look beyond university applications and begin exploring the meaningful value they wish to create in their future careers. Through this initiative, participants are encouraged to discover how science and technology can drive positive impact on human health and society.
“Our core values centre on scientific excellence, patient-centric innovation, and responsible stewardship of technology,” said Ms. Sarah Cheung, COO of Opharmic Technology. “By opening our doors to high school students, we hope to inspire them to see biotechnology not just as an academic subject, but as a powerful platform for solving real-world challenges. We are dedicated to promoting STEM education and helping young minds envision the lasting contributions they can make through science.”
The programme focuses on MeticTouch® (non-invasive ocular drug delivery) and MeticStim® (ultrasound-mediated cell stimulation) platforms, allowing interns to observe and contribute to various stages of medtech development — from laboratory experiments and data analysis to understanding regulatory and commercialization pathways. Activities are structured to be educational, mentorship-driven, and age-appropriate, providing a safe and supportive environment for learning.
This initiative reflects Opharmic’s broader commitment to science education, talent development, and community impact as a local company. By investing in high school students today, the company aims to cultivate a pipeline of future innovators who prioritize purpose-driven careers in biotechnology and beyond.
Applications for the 2024 Rising Star Programme attracted strong interest from motivated students across Hong Kong. Selected participants will benefit from direct mentorship, workshops, and exposure to a professional innovation ecosystem.
Opharmic encourages all eligible high school students and recent graduates passionate about science and innovation to apply in future cycles. Together, we can build the next generation of dedicated scientists and changemakers.
Opharmic Technology